Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.

Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, Neulinger SC, Däumer C, Heinsen FA, Latorre A, Barbas C, Seifert J, dos Santos VM, Ott SJ, Ferrer M, Moya A.

Gut. 2013 Nov;62(11):1591-601. doi: 10.1136/gutjnl-2012-303184. Epub 2012 Dec 12.

2.

Structural alerts for the excess toxicity of acrylates, methacrylates, and propiolates derived from their short-term and long-term bacterial toxicity.

Blaschke U, Eismann K, Böhme A, Paschke A, Schüürmann G.

Chem Res Toxicol. 2012 Jan 13;25(1):170-80. doi: 10.1021/tx200395k. Epub 2011 Dec 30.

PMID:
22117088
3.

Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition.

Mueller SM, Spriewald BM, Bergmann S, Eismann K, Leykauf M, Korn K, Walter H, Schmidt B, Arnold ML, Harrer EG, Kaiser R, Schweitzer F, Braun P, Reuter S, Jaeger H, Wolf E, Brockmeyer NH, Jansen K, Michalik C, Harrer T; German Competence Network for HIV/AIDS.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):109-17. doi: 10.1097/QAI.0b013e3181fe946e.

PMID:
21107269
4.

Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates.

Verheyen J, Schweitzer F, Harrer EG, Knops E, Mueller SM, Däumer M, Eismann K, Bergmann S, Spriewald BM, Kaiser R, Harrer T.

Antivir Ther. 2010;15(6):907-12. doi: 10.3851/IMP1640.

PMID:
20834103
5.

Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.

Hofmann C, Harrer T, Kubesch V, Maurer K, Metzner KJ, Eismann K, Bergmann S, Schmitt-Haendle M, Schuler G, Dörrie J, Schaft N.

AIDS. 2008 Aug 20;22(13):1577-82. doi: 10.1097/QAD.0b013e3283063a17.

PMID:
18670216
6.

Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in Nef.

Maurer K, Harrer EG, Goldwich A, Eismann K, Bergmann S, Schmitt-Haendle M, Spriewald B, Mueller SM, Harrer T; German Competence Network for HIV/AIDS.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):133-41. doi: 10.1097/QAI.0b013e31816fdc4a. Erratum in: J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):343.

PMID:
18391752
7.

Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease.

Mueller SM, Schaetz B, Eismann K, Bergmann S, Bauerle M, Schmitt-Haendle M, Walter H, Schmidt B, Korn K, Sticht H, Spriewald B, Harrer EG, Harrer T.

J Virol. 2007 Mar;81(6):2887-98. Epub 2007 Jan 3.

8.
9.

Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.

Harrer E, Bäuerle M, Ferstl B, Chaplin P, Petzold B, Mateo L, Handley A, Tzatzaris M, Vollmar J, Bergmann S, Rittmaier M, Eismann K, Müller S, Kalden JR, Spriewald B, Willbold D, Harrer T.

Antivir Ther. 2005;10(2):285-300.

PMID:
15865223
10.

A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.

Harrer EG, Bergmann S, Eismann K, Rittmaier M, Goldwich A, Müller SM, Spriewald BM, Harrer T.

AIDS. 2005 Apr 29;19(7):734-5.

PMID:
15821402
11.

Antigenic determinants of the membrane-bound hydrogenase in Alcaligenes eutrophus are exposed toward the periplasm.

Eismann K, Mlejnek K, Zipprich D, Hoppert M, Gerberding H, Mayer F.

J Bacteriol. 1995 Nov;177(21):6309-12.

12.

Regulation of mammalian asparagine synthetase by adenine nucleotides.

Wedler FC, Eismann K.

Biochem Biophys Res Commun. 1976 Apr 5;69(3):798-803. No abstract available.

PMID:
5090

Supplemental Content

Loading ...
Support Center